RhoVac® was a pharmaceutical company dedicated to immuno-oncology, signifying that the body’s own immune system is stimulated to identify and destroy cancer cells. The primary focus of RhoVac® is to develop a cancer therapy that targets metastatic cells to prevent cancer recurrence and progression after primary tumour therapy.